MPO and asthma: Plasma concentrations of the neutrophil-derived mediators MPO, matrix metallopeptidase 9 (MMP-9) and CXCL8 were augmented in patients with asthma compared to healthy subjects [103], which suggests that PMNs are activated in vivo.